The 21st Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), Chicago18 MAY 2018
Presentations and PublicationsRead about publications and presentations made by Benitec's scientific team below. For details of Benitec's announcements to NASDAQ, read details in our Investor Centre.
BB-301: A Single “Silence and Replace” AAV-Based Vector for the Treatment of Oculopharyngeal Muscular Dystrophy (OPMD)
Gene therapy for oculopharyngeal muscular dystrophy
The 22nd International Annual Congress of the World Muscle Society6 OCT 2017
Towards Development of a ‘Silence and Replace’ Based Approach for the Treatment of Oculopharyngeal Muscular Dystrophy.
Joint 10th AGCST and ASSCR Scientific Meeting, Sydney25 MAY 2017
PABPN1 gene therapy for oculopharyngeal muscular dystrophy
Nat. Commun. 8, 14848 doi: 10.1038/ ncomms14848 (2017)1 JAN 2017
Gene Therapy Rescues Disease Phenotype in the Oculopharyngeal Muscular Dystrophy Mouse Model
ASGCT 19th Annual Meeting, Washington DC5 MAY 2016